Liver Cirrhosis - Drug Pipeline Landscape, 2023

Cirrhosis, also known as liver cirrhosis or hepatic cirrhosis and end-stage liver disease, is a condition characterised by impaired liver function caused by the formation of scar tissue known as fibrosis as a result of liver disease damage. Cirrhosis is caused by alcoholic liver disease, non-alcoholic steatohepatitis (NASH), chronic hepatitis B, and chronic hepatitis C.

To Remain 'Ahead' Of Your Competitors, Request for A Sample: https://www.globalinsightservices.com/request-sample/GIS31149

Cirrhosis symptoms emerge slowly until liver damage is extensive. Signs and symptoms include tiredness, weakness, loss of appetite, weight loss, and nausea. Cirrhosis is initially detected through a routine blood test. The other tests, including magnetic resonance elastography (MRE), MRI, CT, and ultrasound, are recommended. To identify the severity, extent, and cause of liver damage, a biopsy is preferred.

The goal of cirrhosis treatment is to slow or prevent the worsening of the condition. A healthy diet is recommended, consisting of a high-protein, high-fiber diet plus supplementation with branched-chain amino acids. Antibiotics are recommended for infections; other medications include carvedilol. Liver transplantation is recommended in cases of uncontrolled conditions.

Read more about Liver Cirrhosis - Drug Pipeline Landscape here: https://www.globalinsightservices.com/reports/liver-cirrhosis-drug-pipeline-landscape

Report Highlights:

Global Insight Service's, Liver Cirrhosis - Drug Pipeline Landscape, 2023 report provides an overview of the Liver Cirrhosis pipeline drugs. This report covers detailed insights on Liver Cirrhosis drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Liver Cirrhosis pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Methodology:

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS31149

Scope:

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clincial trials, and key upcoming milestones are included.

Key Players:

• Abalone Bio Inc
• Akaza Bioscience Ltd
• Akero Therapeutics Inc
• AstraZeneca
• BioVie Inc
• Bristol-Myers Squibb Co
• CellionBioMed Inc
• D&D Pharmatech Co Ltd

For In-Depth Competitive Analysis, Purchase this Report: https://www.globalinsightservices.com/checkout/single_user/GIS31149

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.